739 indapamide sustained release tablet
film coating of 1.
Applications of Terahertz Pulsed Imaging to Sustained Release Tablet
Film Coating Quality Assessment and Dissolution Performance," J.
Fampridine-SR is an oral, small molecule drug contained in a sustained release tablet
Catalytica's R & D arm, which has expanded from 16 to 130 employees since 1997, was key last spring in producing clinical trial batches for a client's sustained release tablet
Stephen Turner, SCOLR Pharma's Vice President and Chief Technology Officer, said, "The data from this second ondansetron study provides additional evidence that our CDT formulation technology is capable of producing a 'once daily' sustained release tablet
About FAMPYRA FAMPYRA is a sustained release tablet
formulation of the drug fampridine (4-aminopyridine, 4-AP or dalfampridine).
This Supply Agreement provides exclusive rights to Nestle Nutrition to market a sustained release tablet
form of SR CarnoSyn(TM) beta-alanine made by NAI, under various existing and pending U.
NASDAQ:CTAL), today announced a new agreement with CV Therapeutics (NASDAQ:CVTX) for supply of a sustained release tablet
form of Ranolazine, which is currently in Phase III clinical trials in the U.
BULLETIN BOARD: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced that it has achieved significant milestones in the development of isosorbide mononitrate sustained release tablet
, a highly effective drug for the prevention and treatment of angina.
In addition, the formulation of XP13512 in a sustained release tablet
resulted in extended exposure to gabapentin and a pharmacokinetic profile that supports a twice daily or less frequent dosing regimen.
For example, Pfizer's blockbuster drug, gabapentin, which is dosed three times daily, is absorbed only within a short segment of the small intestine, preventing its incorporation into a sustained release tablet
," observed Dr.
PDS identified, negotiated and closed more than 25 licensing and development agreements in the areas of oral sustained release tablets
, transdermal delivery systems, needle-free injector devices and solubility enhancement technologies with worldwide leaders in their fields.